Assessment of the efficacy and safety of zoledronic acid in the treatment of bone metastases-related pain in patients with prostate cancer.
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer metastases; Prostate cancer
- Focus Therapeutic Use
- Acronyms TRAPEZE
- Sponsors Novartis
- 10 Jun 2017 Biomarkers information updated
- 17 Dec 2009 Actual patient number (61) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.